EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Berberine potentiates liver inflammation and fibrosis in the PI*Z hAAT transgenic murine model

Yuanqing Lu iD, Naweed S Mohammad, Jungnam Lee, Alek M Aranyos, Karina A Serban, Mark L Brantly iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0310524 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Yuanqing Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Florida, Gainesville, Florida, United States of Americ…. Hauptthemen laut MEDLINE: Berberine, Mice, Transgenic, alpha 1-Antitrypsin, Liver Cirrhosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Alpha-1 Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alpha-1 antitrypsin deficiency (AATD) is an inherited disease, the common variant caused by a Pi*Z mutation in the SERPINA1 gene. Pi*Z AAT increases the risk of pulmonary emphysema and liver disease. Berberine (BBR) is a nature dietary supplement and herbal remedy. Emerging evidence revealed that BBR has remarkable liver-protective properties against various liver diseases. In the present study, we investigated the therapeutic effects and toxicities of BBR in Pi*Z hepatocytes and Pi*Z transgenic mice.

Methods

Huh7.5 and Huh7.5Z (which carries the Pi*Z mutation) cells were treated with different concentrations of BBR for 48 hours. MTT was performed for cell viability assay. Intracellular AAT levels were evaluated by western blot. In vivo studies were carried out in wild type, native phenotype AAT (Pi*M), and Pi*Z AAT transgenic mice. Mice were treated with 50 mg/kg/day of BBR or solvent only by oral administration for 30 days. Western blot and liver histopathological examinations were performed to evaluate therapeutic benefits and liver toxicity of BBR.

Results

BBR reduced intracellular AAT levels in Huh7.5Z cells, meanwhile, no Pi*Z-specific toxicity was observed. However, BBR did not reduce liver AAT load but significantly potentiated liver inflammation and fibrosis accompanying the activation of unfolded protein response and mTOR in Pi*Z mice, but not in wild type and Pi*M mice.

Conclusions

BBR exacerbated liver inflammation and fibrosis specifically in Pi*Z mice. This adverse effect may be associated with the activation of unfolded protein response and mTOR. This study implicates that BBR should be avoided by AATD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BerberineMice, Transgenicalpha 1-AntitrypsinLiver CirrhosisAnimalsMiceHumansDisease Models, AnimalTOR Serine-Threonine KinasesLiverHepatocytesHepatitisUnfolded Protein Response

Substanzen

Berberinealpha 1-AntitrypsinTOR Serine-Threonine Kinases

Autor:innen und Institutionen

  • Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Florida, Gainesville, Florida, United States of America.

ORCID-Profile: Yuanqing Lu, Mark L Brantly

Förderung

  • NHLBI NIH HHS
  • Alpha-1 Foundation

Zitieren

APA

Lu, Y., Mohammad, N. S., Lee, J., Aranyos, A. M., Serban, K. A., & Brantly, M. L. (2024). Berberine potentiates liver inflammation and fibrosis in the PI*Z hAAT transgenic murine model. PLOS ONE. https://doi.org/10.1371/journal.pone.0310524

Vancouver

Lu Y, Mohammad NS, Lee J, Aranyos AM, Serban KA, Brantly ML. Berberine potentiates liver inflammation and fibrosis in the PI*Z hAAT transgenic murine model. PLOS ONE. 2024. doi:10.1371/journal.pone.0310524

BibTeX
@article{Lu2024,
  author = {Lu, Yuanqing and Mohammad, Naweed S and Lee, Jungnam and Aranyos, Alek M and Serban, Karina A and Brantly, Mark L},
  title = {Berberine potentiates liver inflammation and fibrosis in the PI*Z hAAT transgenic murine model},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0310524}
}
Kostenlos starten →